Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Novo Nordisk Limited .
Filed returns
5
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2024 | Novo Nordisk Limited | Health | Engagement with Government regarding the life-sciences sector in Ireland and the EU General Pharmaceutical Legislation (GPL). (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2023 | Novo Nordisk Limited | Health | To discuss the importance of an innovative life science ecosystem in Ireland, outlining Novo Nordisk position on the revision of the EU General Pharmaceutical Legislation. (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2023 | Novo Nordisk Limited | Health | To discuss the importance of an innovative life science ecosystem in Ireland, outlining Novo Nordisk position on the revision of the EU General Pharmaceutical Legislation. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Novo Nordisk Limited | Health | To discuss the importance of an innovative life science ecosystem in Ireland, outlining Novo Nordisk position on the revision of the EU General Pharmaceutical Legislation. (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2022 | Novo Nordisk Limited | Health | To discuss the importance of an innovative ecosystem, including access and reimbursement environment, for a successful life science industry in Ireland to secure our place as a leading life sciences nation for the… (Public policy or programme) | 3 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 5 | 100.0% |